A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Active, not recruiting · NCT03845166 · Registry updated 2024-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, kidney cancer, kidney disorder, neoplasm, rectal disorder, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 1 | 2024-11-19 | NCT03845166 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exelixis | 77 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Exelixis Clinical #70 | London | United Kingdom | 1 |
| Exelixis Clinical #72 | Bordeaux | France | 1 |
| Exelixis Clinical #73 | Naples | Italy | 1 |
| Exelixis Clinical #74 | Cincinnati | United States | 1 |
| Exelixis Clinical #75 | South Brisbane | Australia | 1 |
| Exelixis Clinical #76 | Rotterdam | Netherlands | 1 |
| Exelixis Clinical #77 | Villejuif | France | 1 |
| Exelixis Clinical #78 | New York | United States | 1 |